Skip to content

Evaluating the causal effects of circulating metabolites on major depression disorder.

Sep 2026 · European Archives of Psychiatry and Clinical Neuroscience · 0 citations · 50 references
Medicine

TL;DR

Genetically proxied circulating metabolites showed reproducible associations with MDD, while reverse effects were supported by only two metabolic traits, which may help prioritization of candidate biomarkers for risk stratification in patient cohorts and generate hypotheses for mechanistic research.

View source

Similar papers

Open access Sep 2026

Metabolomic dysregulation in the association between major depressive disorder and chronic pancreatitis: a large prospective cohort study

Background Major depressive disorder (MDD) is increasingly recognized as a systemic condition accompanied by metabolic disturbances, particularly in lipid metabolism. However, whether MDD is associated with the development of chronic pancreatitis (CP), a chronic inflammatory disease with substantial metabolic and nutri...

Wei-Zhen Yang, Chang-Gan Chen, Jun-Peng Li et al. · 0 citations
Open access Sep 2026

816. Frontal structural network vulnerability and peripheral immune dysregulation in major depressive disorder: diagnostic and prognostic implications

Clinically, immune markers facilitate biologically informed MDD subtyping, whereas frontal structural network vulnerability better predicts remission, indicating dissociable roles in diagnosis and prognosis.

W. Du, M. Yuan, Z. Gao et al. · 0 citations
Aug 2026

Association between antidepressant use and the risk of type 2 diabetes: a multi-stage Mendelian randomization study.

Genetic evidence suggesting medication-specific associations between antidepressant use liability and T2D susceptibility is provided, highlighting that the metabolic effects of individual antidepressants may vary, thus, warranting further studies to determine the clinical relevance of the findings.

Dongming Liu, Ancha Baranova, Chenxin Xu et al. · 0 citations
Open access Sep 2026

Genetic and epigenetic architecture of mass spectrometry-derived lipids in blood and their role in lifetime Major Depressive Disorder

The integration analysis showed that genetic variants and DNA methylation at sites annotated to the FADS gene cluster were linked with lipid species that were also associated with lifetime MDD status, while introducing DNA methylation as an additional molecular layer supporting this link.

H. Smith, A. Richmond, M. Adams et al. · 0 citations
Review Open access Sep 2026

Peripheral Inflammatory Biomarkers as Predictors of Antidepressant Treatment Response in Major Depressive Disorder: An Updated Systematic Review and Meta-Analysis.

Lower baseline IL-2 and IL-6 emerge as promising signals for predicting treatment response in contemporary studies (2021-2026) and specific antidepressant classes (SSRIs/SNRIs) and specific antidepressant classes (SSRIs/SNRIs).

H. Chun, Y. Park, Junho Kim et al. · 0 citations
Open access Sep 2026

MTHFR Gene Variants and Major Depressive Disorder in Mexican-Mestizos

Background: Major depressive disorder (MDD) arises from genetic and environmental factors. We evaluated functional variation in methylenetetrahydrofolate reductase (MTHFR), circulating MTHFR protein, and homocysteine (HCY) in Mexican-Mestizo participants. Methods: We analyzed 1507 individuals across four cohorts: a pri...

Miriam Pavelth Casillas-Ávila, C. Toledo-Lozano, L. Á. Montes Almanza et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.